Buscar
Mostrando ítems 1-10 de 80
Understanding the antiangiogenic effect of metronomic chemotherapy through a simple mathematical model
(Elsevier B.V., 2016-12-15)
Despite the current and increasingly successful fight against cancer, there are some important questions concerning the efficiency of its treatment in particular, the design of oncology chemotherapy protocols. Seeking ...
Comparative Effectiveness of Two Metronomic Chemotherapy Schedules—Our Experience in the Preclinical Field
(Taylor, 2014-02)
Metronomic chemotherapy refers to the chronic, equally spaced, delivery of low doses of chemotherapeutic drugs, without extended interruptions. Previously, we developed two combined metronomic schemes for the treatment of ...
Adjuvant thalidomide and metronomic chemotherapy for the treatment of canine malignant mammary gland neoplasms
(2018-11-01)
Background/Aim: The aim of the present study was to evaluate a multimodal approach for the treatment of canine malignant mammary gland neoplasms, including surgery, chemotherapy, thalidomide, and metronomic chemotherapy ...
Metronomic chemotherapy: changing the paradigm that more is better
(Multimed Inc., 2012)
Metronomic chemotherapy in small animal practice: An update
(2016-01-01)
Metronomic chemotherapy can be considered a new chemotherapy modality involving continuous administration of low doses of cytostatic agents which targets endothelial cells. Endothelial cells are vital for the development ...
Toxicity of a methotrexate metronomic schedule in Wistar rats
(2020-10-01)
Metronomic chemotherapy is a relevant strategy that uses low doses of antineoplastic drugs for sustained periods to control tumor growth, an alternative frequently utilized in veterinary patients. This work aimed to evaluate ...
Evaluating the efficacies of Maximum Tolerated Dose and metronomic chemotherapies: A mathematical approach
(Elsevier B.V., 2016-08-15)
We present a mathematical model based on partial differential equations that is applied to understand tumor development and its response to chemotherapy. Our primary aim is to evaluate comparatively the efficacies of two ...
Clinical response in patients with ovarian cancer treated with metronomic chemotherapy
(Cancer Intelligence, 2018)
Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy
(Future Medicine, 2016-05)
Aim: The objective of the study was to detect changes in quality of life (QoL) in metastatic breast cancer patients treated with metronomic chemotherapy with daily low doses of cyclophosphamide and celecoxib. Material & ...